{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:31:50Z","timestamp":1750941110693},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s11427-016-0014-8","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T02:04:33Z","timestamp":1471485873000},"page":"1139-1148","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study"],"prefix":"10.1007","volume":"59","author":[{"given":"Xiangyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengfan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2015.11.001","volume":"22","author":"J. Apperley","year":"2016","unstructured":"Apperley, J., Niederwieser, D., Huang, X., Nagler, A., Fuchs, E., Szer, J., and Kodera, Y. (2016). Haploidentical hematopoietic stem cell transplantation: a global overview comparing Asia, the European Union, and the United States. Biol Blood Marrow Transplant 22, 23\u201326.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","volume":"23","author":"F. Aversa","year":"2005","unstructured":"Aversa, F. (2005). Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23, 3447\u20133454.","journal-title":"J Clin Oncol"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","volume":"31","author":"A. Bashey","year":"2013","unstructured":"Bashey, A., Zhang, X., Sizemore, C.A., Manion, K., Brown, S., Holland, H.K., Morris, L.E., and Solomon, S.R. (2013). T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 31, 1310\u20131316.","journal-title":"J Clin Oncol"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bbmt.2015.06.006","volume":"21","author":"K. Bradstock","year":"2015","unstructured":"Bradstock, K., Bilmon, I., Kwan, J., Blyth, E., Micklethwaite, K., Huang, G., Deren, S., Byth, K., and Gottlieb, D. (2015). Influence of stem cell source on outcomes of allogeneic reduced-intensity conditioning therapy transplants using haploidentical related donors. Biol Blood Marrow Transplant 21, 1641\u20131645.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2014.02.001","volume":"20","author":"L. Castagna","year":"2014","unstructured":"Castagna, L., Crocchiolo, R., Furst, S., Bramanti, S., El Cheikh, J., Sarina, B., Granata, A., Mauro, E., Faucher, C., Mohty, B., Harbi, S., Chabannon, C., Carlo-Stella, C., Santoro, A., and Blaise, D. (2014). Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide. Biol Blood Marrow Transplant 20, 724\u2013729.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-0012.2010.01298.x","volume":"25","author":"Y.J. Chang","year":"2011","unstructured":"Chang, Y.J., and Huang, X.J. (2011). Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin Transplant 25, 13\u201323.","journal-title":"Clin Transplant"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","volume":"20","author":"Y.J. Chang","year":"2014","unstructured":"Chang, Y.J., Zhao, X.Y., and Huang, X.J. (2014). Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20, 440\u2013449.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2012-08-453399","volume":"121","author":"P. Bartolomeo Di","year":"2013","unstructured":"Di Bartolomeo, P., Santarone, S., De Angelis, G., Picardi, A., Cudillo, L., Cerretti, R., Adorno, G., Angelini, S., Andreani, M., De Felice, L., Rapanotti, M.C., Sarmati, L., Bavaro, P., Papalinetti, G., Di Nicola, M., Papola, F., Montanari, M., Nagler, A., and Arcese, W. (2013). Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. Blood 121, 849\u2013857.","journal-title":"Blood"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"A.H. Filipovich","year":"2005","unstructured":"Filipovich, A.H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J.R., Lee, S.J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E.W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J.D., Robinson, M., Schubert, M., Schultz, K., Shulman, H., Turner, M., Vogelsang, G., and Flowers, M.E.D. (2005). National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 11, 945\u2013956.","journal-title":"Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3324\/haematol.10570","volume":"92","author":"X.J. Huang","year":"2007","unstructured":"Huang, X.J., Liu, D.H., Liu, K.Y., Xu, L.P., Chen, H., and Han, W. (2007). Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched\/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica 92, 414\u2013417.","journal-title":"Haematologica"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","volume":"38","author":"X.J. Huang","year":"2006","unstructured":"Huang, X.J., Liu, D.H., Liu, K.Y., Xu, L.P., Chen, H., Han, W., Chen, Y.H., Wang, J.Z., Gao, Z.Y., Zhang, Y.C., Jiang, Q., Shi, H.X., and Lu, D.P. (2006). Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 38, 291\u2013297.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10875-007-9166-z","volume":"28","author":"X.J. Huang","year":"2008","unstructured":"Huang, X.J., Liu, D.H., Liu, K.Y., Xu, L.P., Chen, Y.H., Wang, Y., Han, W., and Chen, H. (2008a). Modified donor lymphocyte infusion after HLA-mismatched\/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia. J Clin Immunol 28, 276\u2013283.","journal-title":"J Clin Immunol"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10875-008-9193-4","volume":"28","author":"X.J. Huang","year":"2008","unstructured":"Huang, X.J., Wang, Y., Liu, D.H., Xu, L.P., Chen, H., Chen, Y.H., Han, W., Shi, H.X., and Liu, K.Y. (2008b). Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia\u2014feasibility and safety study. J Clin Immunol 28, 390\u2013397.","journal-title":"J Clin Immunol"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/bmt.2009.26","volume":"44","author":"X.J. Huang","year":"2009","unstructured":"Huang, X.J., Wang, Y., Liu, D.H., Xu, L.P., Liu, K.Y., Chen, H., Chen, Y.H., Han, W., and Shi, H.X. (2009). Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect. Bone Marrow Transplant 44, 309\u2013316.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s11427-015-4926-0","volume":"58","author":"M. Lv","year":"2015","unstructured":"Lv, M., and Huang, X.J. (2015). Fighting against hematological malignancy in China: from unique system to global impact. Sci China Life Sci 58, 1183\u20131190.","journal-title":"Sci China Life Sci"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/bmt.2011.250","volume":"47","author":"X.D. Mo","year":"2012","unstructured":"Mo, X.D., Xu, L.P., Liu, D.H., Chen, Y.H., Han, W., Zhang, X.H., Chen, H., Wang, Y., Wang, J.Z., Liu, K.Y., and Huang, X.J. (2012). Patients receiving HLA-haploidentical\/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT. Bone Marrow Transplant 47, 1201\u20131205.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbmt.2013.01.026","volume":"19","author":"X.D. Mo","year":"2013","unstructured":"Mo, X.D., Xu, L.P., Liu, D.H., Zhang, X.H., Chen, H., Chen, Y.H., Han, W., Wang, Y., Wang, F.R., Wang, J.Z., Liu, K.Y., and Huang, X.J. (2013). Nonmalignant late effects in survivors of partially matched donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19, 777\u2013783.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/bmt.2014.109","volume":"49","author":"X.D. Mo","year":"2014","unstructured":"Mo, X.D., Zhao, X.Y., Liu, D.H., Chen, Y.H., Xu, L.P., Zhang, X.H., Chen, H., Han, W., Wang, Y., Wang, F.R., Wang, J.Z., Liu, K.Y., and Huang, X.J. (2014). Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances. Bone Marrow Transplant 49, 1070\u20131075.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/bmt.2015.25","volume":"50","author":"I. Pessach","year":"2015","unstructured":"Pessach, I., Resnick, I., Shimoni, A., and Nagler, A. (2015). G-CSF-primed BM for allogeneic SCT: revisited. Bone Marrow Transplant 50, 892\u2013898.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR20","first-page":"825","volume":"15","author":"D. Przepiorka","year":"1995","unstructured":"Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J., and Thomas, E.D. (1995). 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15, 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","volume":"19","author":"A.M. Raiola","year":"2013","unstructured":"Raiola, A.M., Dominietto, A., Ghiso, A., Di Grazia, C., Lamparelli, T., Gualandi, F., Bregante, S., Van Lint, M.T., Geroldi, S., Luchetti, S., Ballerini, F., Miglino, M., Varaldo, R., and Bacigalupo, A. (2013). Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transplant 19, 117\u2013122.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"S.R. Solomon","year":"2012","unstructured":"Solomon, S.R., Sizemore, C.A., Sanacore, M., Zhang, X., Brown, S., Holland, H.K., Morris, L.E., and Bashey, A. (2012). Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Biol Blood Marrow Transplant 18, 1859\u20131866.","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Y. Wang","year":"2014","unstructured":"Wang, Y., Chang, Y.J., Xu, L.P., Liu, K.Y., Liu, D.H., Zhang, X.H., Chen, H., Han, W., Chen, Y.H., Wang, F.R., Wang, J.Z., Chen, Y., Yan, C.H., Huo, M.R., Li, D., and Huang, X.J. (2014a). Who is the best donor for a related HLA haplotype-mismatched transplant?. Blood 124, 843\u2013850.","journal-title":"Blood"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2013.191","volume":"49","author":"Y. Wang","year":"2014","unstructured":"Wang, Y., Fu, H.X., Liu, D.H., Xu, L.P., Zhang, X.H., Chang, Y.J., Chen, Y.H., Wang, F.R., Sun, Y.Q., Tang, F.F., Liu, K.Y., and Huang, X.J. (2014b). Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial. Bone Marrow Transplant 49, 426\u2013433.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cncr.27761","volume":"119","author":"Y. Wang","year":"2013","unstructured":"Wang, Y., Liu, D.H., Liu, K.Y., Xu, L.P., Zhang, X.H., Han, W., Chen, H., Chen, Y.H., Wang, F.R., Wang, J.Z., Sun, Y.Q., and Huang, X.J. (2013). Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia. Cancer 119, 978\u2013985.","journal-title":"Cancer"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/bmt.2011.213","volume":"47","author":"Y. Wang","year":"2012","unstructured":"Wang, Y., Liu, D.H., Xu, L.P., Liu, K.Y., Chen, H., Zhang, X.H., Chen, Y.H., Han, W., Wang, F.R., Wang, J.Z., Yan, C.H., and Huang, X.J. (2012). Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched\/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis. Bone Marrow Transplant 47, 1099\u20131104.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-09-0691","volume":"15","author":"H. Xiao-Jun","year":"2009","unstructured":"Xiao-Jun, H., Lan-Ping, X., Kai-Yan, L., Dai-Hong, L., Yu, W., Huan, C., Yu-Hong, C., Wei, H., Jing-Zhi, W., Yao, C., Xiao-Hui, Z., Hong-Xia, S., Feng-Rong, W., and Fei-Fei, T. (2009). Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies. Clin Cancer Res 15, 4777\u20134783.","journal-title":"Clin Cancer Res"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/bmt.2009.311","volume":"45","author":"L.P. Xu","year":"2010","unstructured":"Xu, L.P., Liu, K.Y., Liu, D.H., Chen, H., Han, W., Chen, Y.H., Wang, Y., and Huang, X.J. (2010). The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched\/haploidentical transplantation: a comparative analysis. Bone Marrow Transplant 45, 985\u2013992.","journal-title":"Bone Marrow Transplant"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ctr.12225","volume":"27","author":"X. Zhao","year":"2013","unstructured":"Zhao, X., Chen, Y., Zhao, X., Liu, D., Xu, L., Wang, Y., Han, W., Chen, Y., Chen, H., Zhang, X., Liu, K., and Huang, X. (2013). Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia. Clin Transplant 27, 844\u2013851.","journal-title":"Clin Transplant"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-016-0014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:54:46Z","timestamp":1498337686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-016-0014-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11427-016-0014-8","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}